The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Live Science on MSN
'DNA origami' could be key for making an effective HIV vaccine, early study hints
A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make ...
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
In an important discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have identified a never-before-seen mechanism that enables the human immunodeficiency ...
A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for ...
Researchers at McGill University have reported that lithium, a long-established treatment for bipolar disorder, suppressed ...
The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection... Can we eliminate the HIV epidemic? It's a question ...
Share on Pinterest Sunleca (lenacapavir) has been shown to be 100% effective at preventing HIV in females. andreswd/Getty Images A new study found that the drug Sunleca (lenacapavir) has been shown to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results